The United States is confronting several infectious-disease threats that many Americans rarely think about: a flesh-destroying bacterium found in warm coastal waters, locally transmitted malaria, and the return of a parasite capable of causing severe damage to livestock.
None of these developments, by themselves, proves that federal spending or staffing cuts caused an outbreak. Pathogens spread for many reasons, including climate conditions, travel, animal movement and gaps in local prevention.
But the threats are emerging as the federal government reduces the size of major health and agricultural agencies, withdraws from some international health partnerships, and reorganizes programs responsible for surveillance and response. That timing has intensified a debate over how much public-health capacity the country can remove without weakening its defenses.
A significantly smaller federal health workforce
In March 2025, the Department of Health and Human Services announced a restructuring intended to reduce its workforce from approximately 82,000 to 62,000 employees. HHS said the transformation would consolidate divisions, centralize administrative functions and save taxpayers an estimated $1.8 billion annually.
The department maintained that the restructuring would eliminate duplication without affecting critical services. Its plan included approximately 10,000 job reductions in addition to departures through early-retirement and resignation programs.
Supporters of the changes view the reductions as overdue reform of a large bureaucracy. Critics argue that head-count totals do not show which specialized capabilities may be lost when experienced epidemiologists, laboratory staff, veterinarians and program managers leave.
That distinction matters because disease surveillance is not simply a database that operates automatically. It depends on laboratories identifying pathogens, clinicians reporting unusual cases, local officials investigating them and specialists connecting information across jurisdictions.
Vibrio vulnificus is rare, but exceptionally dangerous
One immediate concern is Vibrio vulnificus, a bacterium that naturally occurs in warm coastal water. People can become infected when seawater enters an open wound or when they consume contaminated raw or undercooked seafood, particularly oysters.
The Centers for Disease Control and Prevention says the infection can lead to intensive-care treatment or limb amputation. Approximately one in five infected people die, sometimes within one or two days after becoming ill.
CDC surveillance recorded 3,743 cases of vibriosis in 2024, including 222 involving V. vulnificus. Across all reported Vibrio species in that dataset, 1,050 patients were hospitalized and 73 died.
The danger is not evenly distributed. Severe illness is more likely among people with liver disease, diabetes, weakened immune systems and certain other underlying conditions. The practical advice remains straightforward: avoid raw shellfish, keep open wounds away from coastal or brackish water, and seek urgent medical care when rapidly worsening redness, swelling, blistering, fever or severe pain follows water exposure.
The larger policy question is whether federal and state systems will continue to detect changes in the bacterium's geographic range and identify clusters quickly enough. FoodNet, a federal-state surveillance network, has historically monitored laboratory-confirmed infections across participating sites, including Vibrio infections. The network covers roughly 15% of the U.S. population and operates through collaboration among CDC, state health departments, the Food and Drug Administration and the Department of Agriculture.
Federal officials have argued that national surveillance does not depend on one program alone and that other systems continue to provide visibility into foodborne disease. Public-health critics counter that reducing the consistency or depth of active surveillance can make trends more difficult to interpret.
That disagreement should not be simplified into a claim that surveillance has disappeared. The more defensible concern is that fragmented or less detailed reporting may delay recognition of changing patterns.
Malaria remains capable of returning locally
Malaria was eliminated as an endemic disease in the United States in the early 1950s, but the mosquitoes capable of transmitting it remain present in parts of the country.
In updated 2026 guidance, CDC said the United States remains susceptible to malaria reintroduction. An infected traveler can carry the parasite into the country, after which a local mosquito can potentially transmit it to another person. The level of risk varies according to mosquito ecology, geography, climate, travel and public-health capacity.
That is not merely theoretical. Locally acquired mosquito-transmitted cases were identified in several states in 2023, producing the first such U.S. outbreaks in roughly two decades. The experience contributed to CDC's decision to update its operational guidance for investigating suspected domestic transmission.
Domestic readiness is connected to international control. Most U.S. malaria cases are associated with travel, so reducing transmission abroad also reduces the number of infections that can be imported.
The President's Malaria Initiative, traditionally implemented through USAID and CDC, has funded mosquito control, diagnostic testing, treatment, preventive medicines and bed-net distribution in heavily affected countries. A 2025 USAID Office of Inspector General report said the initiative and its partners had helped prevent approximately 2.2 billion malaria cases and save 12.7 million lives since 2000.
Interruptions to such programs do not automatically produce malaria transmission inside the United States. The chain of causation is much longer. But cuts to overseas prevention can increase disease burden abroad, while diminished domestic expertise can make imported or locally transmitted cases more difficult to investigate.
Screwworm's return shows why animal surveillance matters
New World screwworm presents a different type of threat. Its larvae feed on living tissue after adult flies lay eggs in wounds. The parasite primarily affects livestock, wildlife and pets, although human infestation is possible.
USDA confirmed the first U.S. detection in a calf in Zavala County, Texas, on June 3, 2026. Additional cases followed in Texas and New Mexico, and by June 9 the department said the total had reached six.
USDA says the current danger to people and animals nationally remains very low and stresses that screwworm is not a food-safety threat. The agency is coordinating surveillance, trapping, investigation and control measures with state authorities.
The federal response is taking place after substantial staff losses at USDA. An inspector-general review examined agency staffing and attrition during the first half of 2025, amid broader concern about whether workforce reductions left some offices with less operational capacity.
It would be inaccurate to conclude from timing alone that USDA personnel cuts caused screwworm to cross into the United States. The parasite had already been moving north through the Americas, and CDC warned in January 2026 about cases in the Mexican state of Tamaulipas, which borders Texas.
The stronger question is whether a smaller agency can sustain a prolonged response if detections spread across additional counties or states.
Animal-health emergencies can demand intensive fieldwork: inspecting animals, identifying larvae, operating traps, tracing movements, coordinating quarantines and producing sterile flies used to disrupt reproduction. The impact of staffing losses may therefore become clearer over months, rather than during the first days of an outbreak.
The international surveillance gap
Disease protection does not begin at the U.S. border. Federal agencies rely on information from foreign ministries, international organizations, researchers and nongovernmental groups to identify outbreaks before infected travelers, animals or goods reach the country.
President Donald Trump ordered the United States to begin withdrawing from the World Health Organization on January 20, 2025. The administration argued that WHO mishandled the COVID-19 pandemic, failed to implement necessary reforms and demanded disproportionate financial contributions from the United States.
The withdrawal reflects a broader policy preference for greater national control over health decisions. Critics warn that stepping away from established international systems may reduce access to early outbreak intelligence and make coordination more complicated during cross-border emergencies.
Again, the consequences are not binary. U.S. agencies can maintain bilateral relationships, collect their own intelligence and cooperate with countries outside WHO channels. But replacing a global reporting network would require its own funding, staff and agreements. International disengagement saves little operational capacity if the government must rebuild parallel systems to obtain similar information.
Cuts do not cause pathogens, but capacity shapes the outcome
The emerging threats have different origins.
Vibrio is influenced by water temperature, salinity, seafood consumption and wound exposure. Malaria depends on infected people, competent mosquito vectors and local conditions that allow transmission. Screwworm spreads through animal hosts and fly populations.
Federal workforce reductions did not create those biological mechanisms.
Public-health capacity affects what happens next: how quickly an unusual case is recognized, whether laboratories can confirm it, whether agencies can connect related cases, and how rapidly officials can warn the public or deploy countermeasures.
That is why the central policy dispute cannot be resolved simply by counting outbreaks. A surveillance system can appear unnecessary precisely when it is succeeding. Prevention often produces an absence of visible events, while the effects of weakened capacity may not emerge until a system faces an unusually demanding emergency.
The administration argues that consolidation will make agencies more accountable and efficient while protecting essential functions. That claim should be judged against measurable outcomes: laboratory turnaround times, outbreak-investigation speed, reporting completeness, staffing in specialized units and the time required to deploy assistance to affected communities.
Critics should face the same evidentiary standard. It is reasonable to warn that losing expertise creates risk, but specific outbreaks should not be attributed to federal cuts without evidence demonstrating a causal link.
What readers should watch
The most revealing developments will not necessarily be the total number of infectious-disease headlines. More useful indicators include:
- Whether state and federal laboratories experience testing delays.
- Whether disease reports become less complete or less geographically detailed.
- Whether agencies can fill specialized scientific and veterinary positions.
- Whether local health departments receive timely federal assistance.
- Whether international outbreak information continues reaching U.S. officials quickly.
- Whether emergency responses can be sustained after the initial publicity fades.
The United States still has extensive public-health infrastructure, skilled state agencies, university laboratories and sophisticated disease-monitoring systems. The question is not whether all protection vanished when programs were cut.
It is whether the remaining system has enough depth and redundancy to manage several threats at once.
As Vibrio, malaria and screwworm demonstrate, organisms do not adjust their behavior to federal budget cycles. Efficiency reforms may ultimately preserve essential services with fewer employees. But if staffing and surveillance are reduced beyond that point, the cost may first appear not in a budget document, but in the time lost before the next dangerous outbreak is recognized.
Editorial source note
This article was independently organized and written from government publications and public-health records.
Primary sources
- U.S. Department of Health and Human Services, 2025 restructuring announcement and fact sheet.
- CDC, About and prevention guidance for Vibrio infections.
- CDC, 2024 Cholera and Other Vibrio Illness Surveillance summary.
- CDC, 2026 operational guidance on locally acquired malaria.
- USAID Office of Inspector General, assessment of the President's Malaria Initiative.
- USDA APHIS, 2026 New World screwworm detections and federal response.
- USDA Office of Inspector General, review of USDA staffing levels.
- The White House, order initiating U.S. withdrawal from WHO.
- KFF Health News, original investigation that prompted the topic.